Role of the proteasome in the regulation of fetal fibronectin secretion in human placenta

Annals of the New York Academy of Sciences

Volumn 943, Issue , 2001, Pages 340-351

  Ma, Yuehong ^a   D'Antona, Donato ^a   LaChapelle, Linda ^a   Ryu, Jae Shin ^a   Guller, Seth ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytotrophoblasts; Fetal fibronectin; Fibronectin; Placenta; Placental mesenchymal cells; Proteasome; Serum free medium

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CALPAIN; FIBRONECTIN; INTERLEUKIN 8; MESSENGER RNA; MG 262; PROTEASOME; PROTEINASE INHIBITOR; SALAZOSULFAPYRIDINE; SERINE PROTEINASE; UBIQUITIN; UNCLASSIFIED DRUG;

CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; CYTOTROPHOBLAST; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; LYSOSOME; MESENCHYME CELL; NORTHERN BLOTTING; PLACENTA; PROTEIN DEGRADATION; PROTEIN SECRETION; REGULATORY MECHANISM; WESTERN BLOTTING;

EID: 0034803439     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb03814.x     Document Type: Conference Paper

References (28)

1. Degradation of CFTR by the ubiquitin-proteasome pathway
2. Degradation of subunits of the Sec61p complex, an integral component of the ER membrane, by the ubiquitin-proteasome pathway
3. Retrograde protein translocation: ERADication of secretory proteins in health and disease
4. The oncofetal domain of fibronectin defined by the monoclonal antibody FDC-6: Its presence in fibronectins from fetal and tumor tissues and its absence in those normal adult tissues and plasma
5. The oncofetal structure of human fibronectin defined by monoclonal antibody FDC-6
6. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery
7. Is oncofetal fibronectin a trophoblast glue for human implantation?
8. 1
9. Steroid regulation of oncofetal fibronectin expression in human cytotrophoblasts
10. Cell type-specific regulation of fetal fibronectin expression in amnion: Conservation of glucocorticoid responsiveness in human and nonhuman primates
11. Characterization of cytochrome P4502E1 turnover in transfected HepG2 cells expressing human CYP2E1
12. Developmental regulation of glucocorticoid-mediated effects on extracellular matrix protein expression in the human placenta
13. Glucocorticoid effects in the human placenta: Evidence that dexamethasone-mediated inhibition of fibronectin expression in cytotrophoblasts involves a protein intermediate
14. Glucocorticoid suppression of human placental fibronectin expression: Implications in uterine-placental adherence
15. Opposing actions of transforming growth factor-β and glucocorticoids in the regulation of fibronectin expression in the human placenta
16. Chronic antagonism of nuclear factor κB activity in cytotrophoblasts by dexamethasone: A potential mechanism for antiinflammatory action of glucocorticoids in human placenta
17. Expression of Fas ligand by human cytotrophoblasts: Implications in placentation and fetal survival
18. Active site-directed inhibitors of the Rhodococcus 20S proteasome. Kinetics and mechanism
19. Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: Identification and characterization of the conjugating enzymes
20. The degradation of nascent fibrinogen chains is mediated by the ubiquitin proteasome pathway
21. The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix
22. Fibronectins: From gene to protein
23. Proteolytic remodeling of extracellular matrix
24. Limited cleavage of cellular fibronectin by plasminogen activator purified from transformed cells
25. Regulation of urokinase-type plasminogen activator production by cultured human cytotrophoblasts
26. Fibronectinase activity in cultured human trophoblasts is mediated by urokinase-type plasminogen activator
27. Latent fibronectin-degrading serine proteinase activity in N-terminal heparin-binding domain of human plasma fibronectin
28. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells